Aspirin (rectal): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
{{DrugProjectFormSinglePage
{{DrugProjectFormSinglePage
|aOrAn=a
|authorTag={{Ammu}}
|OTC=Yes
|genericName=Aspirin suppository
|aOrAn=an
|drugClass=[[analgesic]]
|indicationType=treatment
|indicationType=treatment
|hasBlackBoxWarning=Yes
|indication=minor aches, pains and headache and for reduction of fever
|adverseReactions=<!--Black Box Warning-->
|adverseReactions=[[hypoprothrombinemia]], [[thrombocytopenia]], [[hypersensitivity]], [[cholestatic hepatitis]], [[tinnitus]]
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
|blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
Line 12: Line 16:


<!--FDA-Labeled Indications and Dosage (Adult)-->
<!--FDA-Labeled Indications and Dosage (Adult)-->
|fdaLIADAdult======Condition1=====
|fdaLIADAdult======Indication=====
* For the relief of minor aches, pains and headache and for reduction of fever.
=====Dosage=====
Remove suppository from plastic packet and insert into the rectum as far as possible. Adult: One suppository every 4 hours for no more than 10 days or as directed by a physician. Children under 12 years of age: Consult a physician.


* Dosing Information
|offLabelAdultGuideSupport=
 
:* Dosage
 
=====Condition2=====
 
* Dosing Information
 
:* Dosage
 
=====Condition3=====
 
* Dosing Information
 
:* Dosage
 
=====Condition4=====
 
* Dosing Information
 
:* Dosage
 
<!--Off-Label Use and Dosage (Adult)-->
 
<!--Guideline-Supported Use (Adult)-->
|offLabelAdultGuideSupport======Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====


There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


<!--Non–Guideline-Supported Use (Adult)-->
<!--Non–Guideline-Supported Use (Adult)-->
|offLabelAdultNoGuideSupport======Condition1=====
|offLabelAdultNoGuideSupport=
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.


Line 69: Line 32:


<!--FDA-Labeled Indications and Dosage (Pediatric)-->
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed======Condition1=====
|fdaLIADPed=
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====


There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
Line 82: Line 39:


<!--Guideline-Supported Use (Pediatric)-->
<!--Guideline-Supported Use (Pediatric)-->
|offLabelPedGuideSupport======Condition1=====
|offLabelPedGuideSupport=
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Non–Guideline-Supported Use (Pediatric)-->
<!--Non–Guideline-Supported Use (Pediatric)-->
|offLabelPedNoGuideSupport======Condition1=====
|offLabelPedNoGuideSupport=
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====


There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.


<!--Contraindications-->
<!--Contraindications-->
|contraindications=* Condition1
<!--Warnings-->
|warnings=* Description
====Precautions====
* Description
<!--Adverse Reactions-->
<!--Clinical Trials Experience-->
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
=====Body as a Whole=====
=====Cardiovascular=====
=====Digestive=====
=====Endocrine=====
=====Hematologic and Lymphatic=====
=====Metabolic and Nutritional=====
=====Musculoskeletal=====
=====Neurologic=====
=====Respiratory=====
=====Skin and Hypersensitivy Reactions=====
=====Special Senses=====
=====Urogenital=====
=====Miscellaneous=====
<!--Postmarketing Experience-->
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
=====Body as a Whole=====
=====Cardiovascular=====
=====Digestive=====
=====Endocrine=====
=====Hematologic and Lymphatic=====
=====Metabolic and Nutritional=====
=====Musculoskeletal=====
=====Neurologic=====




=====Respiratory=====
|postmarketing=[[Hypoprothrombinemia]], [[thrombocytopenia]], [[hypersensitivity]], [[cholestatic hepatitis]], [[tinnitus]]
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
=====Special Senses=====
 
 
 
=====Urogenital=====
 
 
 
=====Miscellaneous=====
 
 
 
<!--Drug Interactions-->
|drugInteractions=* Drug
|drugInteractions=* Drug
:* Description
:* Description
Line 264: Line 72:


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->
|administration=* Oral
|administration=* Rectal
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.


* Intravenous
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.


* Description


<!--IV Compatibility-->
<!--IV Compatibility-->
Line 275: Line 81:


<!--Overdosage-->
<!--Overdosage-->
|overdose====Acute Overdose===
====Signs and Symptoms====
* Description
====Management====
* Description
===Chronic Overdose===
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
<!--Pharmacology-->
<!--Drug box 2-->
|drugBox=<!--Mechanism of Action-->
|drugBox=<!--Mechanism of Action-->
|mechAction=*  
|mechAction=*  
Line 313: Line 102:


<!--How Supplied-->
<!--How Supplied-->
|howSupplied=*
|howSupplied=* Suppositories sealed in imprinted plastic packet.
|storage=* Do not use if imprinted packet is opened or damaged. Store in a cool place 8˚- 15˚C (46˚- 59˚F) or refrigerate.
|packLabel=<!--Patient Counseling Information-->
|packLabel=<!--Patient Counseling Information-->
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
Line 321: Line 111:


<!--Brand Names-->
<!--Brand Names-->
|brandNames=* ®<ref>{{Cite web | title =  | url = }}</ref>
|brandNames=* ASPIRIN®<ref>{{Cite web | title = ASPIRIN- aspirin suppository | url = http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cce244aa-cd79-49c8-b68e-267f2bd0ef67}}</ref>


<!--Look-Alike Drug Names-->
<!--Look-Alike Drug Names-->

Revision as of 20:41, 5 May 2015

Aspirin (rectal)
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Overview

Aspirin (rectal) is an analgesic that is FDA approved for the treatment of minor aches, pains and headache and for reduction of fever. Common adverse reactions include hypoprothrombinemia, thrombocytopenia, hypersensitivity, cholestatic hepatitis, tinnitus.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indication
  • For the relief of minor aches, pains and headache and for reduction of fever.
Dosage

Remove suppository from plastic packet and insert into the rectum as far as possible. Adult: One suppository every 4 hours for no more than 10 days or as directed by a physician. Children under 12 years of age: Consult a physician.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (rectal) in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (rectal) in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Aspirin (rectal) in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Aspirin (rectal) in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Aspirin (rectal) in pediatric patients.

Contraindications

There is limited information regarding Aspirin (rectal) Contraindications in the drug label.

Warnings

There is limited information regarding Aspirin (rectal) Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Aspirin (rectal) in the drug label.

Postmarketing Experience

Hypoprothrombinemia, thrombocytopenia, hypersensitivity, cholestatic hepatitis, tinnitus

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Aspirin (rectal) in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Aspirin (rectal) during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Aspirin (rectal) with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Aspirin (rectal) with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Aspirin (rectal) with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Aspirin (rectal) with respect to specific gender populations.

Race

There is no FDA guidance on the use of Aspirin (rectal) with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Aspirin (rectal) in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Aspirin (rectal) in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Aspirin (rectal) in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Aspirin (rectal) in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Rectal

Monitoring

There is limited information regarding Monitoring of Aspirin (rectal) in the drug label.

IV Compatibility

There is limited information regarding IV Compatibility of Aspirin (rectal) in the drug label.

Overdosage

There is limited information regarding Aspirin (rectal) overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Aspirin (rectal) Pharmacology in the drug label.

Mechanism of Action

Structure

File:Aspirin (rectal)01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Aspirin (rectal) in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Aspirin (rectal) in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Aspirin (rectal) in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Aspirin (rectal) in the drug label.

How Supplied

  • Suppositories sealed in imprinted plastic packet.

Storage

  • Do not use if imprinted packet is opened or damaged. Store in a cool place 8˚- 15˚C (46˚- 59˚F) or refrigerate.

Images

Drug Images

{{#ask: Page Name::Aspirin (rectal) |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Aspirin (rectal) |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Aspirin (rectal) in the drug label.

Precautions with Alcohol

  • Alcohol-Aspirin (rectal) interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ "ASPIRIN- aspirin suppository".
  2. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Label Page=Aspirin (rectal)
 |Label Name=Aspirin (rectal)11.png

}}

{{#subobject: 

 |Label Page=Aspirin (rectal)
 |Label Name=Aspirin (rectal)11.png

}}

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Aspirin_(rectal)&oldid=1094466"